Woodline Partners’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
Woodline Partners's OLMA Position: Q3 2026 in Review
Woodline Partners reduced its Olema Oncology (OLMA) stake by 22% in Q3 2026, selling an estimated $1.78M and leaving 588,030 shares worth $5.08M. The position accounts for 0.02% of the portfolio, ranked #713.
Woodline Partners first reported a position in OLMA in Q2 2023 and has held it in 14 quarters since. The position peaked at $37M in Q4 2025. 177 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- Woodline Partners held 588,030 shares of Olema Oncology worth $5.08M as of Q3 2026.
- Woodline Partners sold 163,000 Olema Oncology shares in Q3 2026, an estimated $1.78M.
- Olema Oncology made up 0.02% of Woodline Partners's portfolio in Q3 2026, its #713 holding.
- Woodline Partners first reported a position in Olema Oncology in Q2 2023 and has held it in 14 quarters since.
- Woodline Partners's Olema Oncology position peaked at $37M in Q4 2025.
- 177 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.